Xiaobing Yu, MD
Associate Professor
Anesthesia
School of Medicine

These include mouth or face pain (such as trigeminal neuralgia), failed back surgery syndrome, facetogenic pain (involving the facet joints of the spine's vertebrae), neuropathic pain, complex regional pain syndrome and pain associated with cancer.

Yu's research explores new treatments for neuropathic pain, with the goal of improving the standard of care for this chronic condition.

After earning his medical degree at Peking Union Medical College, Yu completed a residency in anesthesiology at Brigham and Women's Hospital, an affiliate of Harvard Medical School. He completed a fellowship in pain medicine at UCSF before joining the faculty.

Yu belongs to the American Society of Anesthesiologists, California Society of Anesthesiologists, American Society of Regional Anesthesia and Pain Medicine, and International Association for the Study of Pain.

Yu has a strong commitment to medical education. He directs the chronic pain rotation for UCSF residents as well as a specialty training course in pain management.

• Rapid Isolation of Dorsal Root Ganglion Macrophages.
  Journal of visualized experiments : JoVE 2019 Yu X, Leff J, Guan Z
• Integrating Patient-Controlled Analgesia Using Implanted Intrathecal Pumps for Postoperative Pain Management: A Case Report.
  A&A practice 2018 Peniche A, Poree L, Schumacher M, Yu X
• T-cell acute leukemia 1 (TAL1) regulation of erythropoietin receptor and association with excessive erythrocytosis.
  The Journal of biological chemistry 2012 Rogers H, Wang L, Yu X, Alnaeeli M, Cui K, Zhao K, Bieker JJ, Prchal J, Huang S, Weksler B, Noguchi CT
• Erythropoietin signaling promotes transplanted progenitor cell survival.
  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2009 Jia Y, Warin R, Yu X, Epstein R, Noguchi CT
• Notch signaling activation in human embryonic stem cells is required for embryonic, but not trophoblastic, lineage commitment.
  Cell stem cell 2008 Yu X, Zou J, Ye Z, Hammond H, Chen G, Tokunaga A, Mali P, Li YM, Civin C, Gaiano N, Cheng L
• Kruppel-like factor 4 is essential for inflammatory monocyte differentiation in vivo.
  Journal of immunology (Baltimore, Md. : 1950) 2008 Alder JK, Georgantas RW, Hildreth RL, Kaplan IM, Morisot S, Yu X, McDevitt M, Civin CI
• Hypoxia alters progression of the erythroid program.
  Experimental hematology 2007 Rogers HM, Yu X, Wen J, Smith R, Fibach E, Noguchi CT
• Modification of globin gene expression by RNA targeting strategies.
  Experimental hematology 2007 Shen TJ, Rogers H, Yu X, Lin F, Noguchi CT, Ho C
• A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing.
  Nature genetics 2007 Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, Mohammad HP, Chen W, Daniel VC, Yu W, Berman DM, Jenuwein T, Pruitt K, Sharkis SJ, Watkins DN, Herman JG, Baylin SB
• HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding.
  Stem cells (Dayton, Ohio) 2006 Yu X, Alder JK, Chun JH, Friedman AD, Heimfeld S, Cheng L, Civin CI
• Tal1/SCL binding to pericentromeric DNA represses transcription.
  The Journal of biological chemistry 2005 Wen J, Huang S, Pack SD, Yu X, Brandt SJ, Noguchi CT
• Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas.
  Development (Cambridge, England) 2004 Esni F, Ghosh B, Biankin AV, Lin JW, Albert MA, Yu X, MacDonald RJ, Civin CI, Real FX, Pack MA, Ball DW, Leach SD
• Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells.
  Blood 2004 Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, Noguchi CT
• High-efficiency stable gene transduction in primary human melanocytes using a lentiviral expression system.
  The Journal of investigative dermatology 2004 Dunlap S, Yu X, Cheng L, Civin CI, Alani RM
• Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells.
  Molecular therapy : the journal of the American Society of Gene Therapy 2003 Yu X, Zhan X, D'Costa J, Tanavde VM, Ye Z, Peng T, Malehorn MT, Yang X, Civin CI, Cheng L
• Erythropoietin receptor signalling is required for normal brain development.
  Development (Cambridge, England) 2002 Yu X, Shacka JJ, Eells JB, Suarez-Quian C, Przygodzki RM, Beleslin-Cokic B, Lin CS, Nikodem VM, Hempstead B, Flanders KC, Costantini F, Noguchi CT
• Pathophysiology of a sickle cell trait mouse model: human alpha(beta)(S) transgenes with one mouse beta-globin allele.
  Blood cells, molecules & diseases 2001 Noguchi CT, Gladwin M, Diwan B, Merciris P, Smith R, Yu X, Buzard G, Fitzhugh A, Keefer LK, Schechter AN, Mohandas N
• The human erythropoietin receptor gene rescues erythropoiesis and developmental defects in the erythropoietin receptor null mouse.
  Blood 2001 Yu X, Lin CS, Costantini F, Noguchi CT
• Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts.
  The Journal of biological chemistry 2000 Ogilvie M, Yu X, Nicolas-Metral V, Pulido SM, Liu C, Ruegg UT, Noguchi CT
• Production and processing of erythropoietin receptor transcripts in brain.
  Brain research. Molecular brain research 2000 Chin K, Yu X, Beleslin-Cokic B, Liu C, Shen K, Mohrenweiser HW, Noguchi CT